PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors - Gros, Alena; Robbins, Paul F; Yao, Xin; Li, Yong F; Turcotte, Simon; Tran, Eric; Wunderlich, John R; Mixon, Arnold; Farid, Shawn; Dudley, Mark E; Hanada, Ken-Ichi; Almeida, Jorge R; et al. (The Journal of clinical investigation, 2014)
Keywords: Adoptive Transfer; Antigens, CD - genetics; Antigens, CD - immunology; CD8-Positive T-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - pathology; Cell Line, Tumor; Female; Hepatitis A Virus Cellular Receptor 2; Humans; Male; Melanoma - genetics; Melanoma - immunology; Melanoma - pathology; Melanoma - therapy; Membrane Proteins - genetics; Membrane Proteins - immunology; Programmed Cell Death 1 Receptor - genetics; Programmed Cell Death 1 Receptor - immunology; Receptors, Antigen, T-Cell, alpha-beta - genetics; Receptors, Antigen, T-Cell, alpha-beta - immunology; Tumor Microenvironment - genetics; Tumor Microenvironment - immunology; Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics; Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology